Contracts Finder · Award
Pharmaceuticals used for Nicotine Replacement Therapy
A public procurement published by Thurrock Council via Contracts Finder.
- £208k
- Award value
- £208k
- Tender value
- 1
- Suppliers
- 1
- Awards
- 3
- Notices
- Award
- Stage
Overview
Thurrock Council is seeking to appoint a Supplier to provide Supplies to be used for Nicotine Replacement Therapy (NRT). Note the contract value includes an optional one year extension period.
Key details
- Buyer
- Thurrock Council
- Source
- Contracts Finder
- Lifecycle stage
- Award
- Status
- active
- CPV classification
- 33693200 — Nicotine substitutes
- Currency
- GBP
- Total award value
- £208,000
- Tender value
- £208,000
- First published
- 21 Apr 2020
- Last updated
- 1 Jul 2020
Awards
1 award recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Sigma Pharmaceuticals PLC | 01561802 | 23 Jun 2020 | active | £208k |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from Thurrock Council
FAQs about this procurement
Who is the buyer for "Pharmaceuticals used for Nicotine Replacement Therapy"?
Pharmaceuticals used for Nicotine Replacement Therapy is a UK public-sector procurement published by Thurrock Council via Contracts Finder.
Has "Pharmaceuticals used for Nicotine Replacement Therapy" been awarded?
Yes — 1 award is recorded, with a reported total value of £208,000. The current lifecycle stage is "Award".
Which suppliers are involved in "Pharmaceuticals used for Nicotine Replacement Therapy"?
1 supplier is linked: Sigma Pharmaceuticals PLC.
What is "Pharmaceuticals used for Nicotine Replacement Therapy" worth?
The reported award value is £208,000.
When was "Pharmaceuticals used for Nicotine Replacement Therapy" published?
It was first published on 21 Apr 2020 and last updated on 1 Jul 2020, across 3 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable